DermaSpace Deutschland ApS — Credit Rating and Financial Key Figures
CVR number: 41170875
Niels Bohrs Vej 21 B, Stilling 8660 Skanderborg
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | -5.92 | -8.10 | -6.80 | -32.11 |
| EBIT | -5.92 | -8.10 | -6.80 | -32.11 |
| Other financial expenses | -0.21 | -0.29 | -2.99 | -1.57 |
| Pre-tax profit | -6.13 | -8.39 | -9.79 | -33.68 |
| Income taxes | 0.93 | 1.52 | 1.53 | -3.97 |
| Net earnings | -5.20 | -6.88 | -8.26 | -37.65 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Tangible assets total | ||||
| Investments total | ||||
| Long term receivables total | ||||
| Inventories total | ||||
| Current other receivables | 14.64 | 1.35 | ||
| Current deferred tax assets | 0.93 | 2.44 | 3.97 | |
| Short term receivables total | 0.93 | 2.44 | 18.61 | 1.35 |
| Cash and bank deposits | 37.87 | 37.48 | 20.61 | 56.46 |
| Cash and cash equivalents | 37.87 | 37.48 | 20.61 | 56.46 |
| Balance sheet total (assets) | 38.80 | 39.92 | 39.23 | 57.81 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 |
| Retained earnings | -5.20 | -12.08 | -20.34 | |
| Profit of the financial year | -5.20 | -6.88 | -8.26 | -37.65 |
| Shareholders equity total | 34.80 | 27.92 | 19.66 | -17.99 |
| Non-current liabilities total | ||||
| Current loans from credit institutions | 12.72 | |||
| Current trade creditors | 4.00 | 12.00 | 4.00 | 4.00 |
| Other non-interest bearing current liabilities | 2.84 | 71.80 | ||
| Current liabilities total | 4.00 | 12.00 | 19.56 | 75.80 |
| Balance sheet total (liabilities) | 38.80 | 39.92 | 39.23 | 57.81 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.